AIRLINK 65.04 Increased By ▲ 0.45 (0.7%)
BOP 5.67 Increased By ▲ 0.07 (1.25%)
CNERGY 4.78 Increased By ▲ 0.06 (1.27%)
DFML 22.32 Increased By ▲ 1.56 (7.51%)
DGKC 71.00 Decreased By ▼ -0.40 (-0.56%)
FCCL 19.80 Decreased By ▼ -0.15 (-0.75%)
FFBL 30.68 Increased By ▲ 0.23 (0.76%)
FFL 10.21 Increased By ▲ 0.16 (1.59%)
GGL 10.03 Decreased By ▼ -0.02 (-0.2%)
HBL 113.50 Increased By ▲ 2.50 (2.25%)
HUBC 131.25 Increased By ▲ 0.41 (0.31%)
HUMNL 6.80 Decreased By ▼ -0.05 (-0.73%)
KEL 4.45 Increased By ▲ 0.06 (1.37%)
KOSM 4.36 Increased By ▲ 0.02 (0.46%)
MLCF 37.45 Decreased By ▼ -0.30 (-0.79%)
OGDC 134.20 Increased By ▲ 0.35 (0.26%)
PAEL 22.70 Increased By ▲ 0.13 (0.58%)
PIAA 27.43 Decreased By ▼ -0.12 (-0.44%)
PIBTL 6.39 Increased By ▲ 0.08 (1.27%)
PPL 115.75 Increased By ▲ 0.80 (0.7%)
PRL 27.57 Increased By ▲ 0.35 (1.29%)
PTC 16.81 Increased By ▲ 0.31 (1.88%)
SEARL 60.82 Increased By ▲ 0.12 (0.2%)
SNGP 66.25 Increased By ▲ 1.10 (1.69%)
SSGC 11.30 Decreased By ▼ -0.05 (-0.44%)
TELE 9.13 Increased By ▲ 0.16 (1.78%)
TPLP 11.25 No Change ▼ 0.00 (0%)
TRG 69.54 Increased By ▲ 0.49 (0.71%)
UNITY 23.50 Increased By ▲ 0.06 (0.26%)
WTL 1.42 Increased By ▲ 0.03 (2.16%)
BR100 7,368 Increased By 43.3 (0.59%)
BR30 24,263 Increased By 205.2 (0.85%)
KSE100 70,823 Increased By 278.8 (0.4%)
KSE30 23,290 Increased By 98.4 (0.42%)

AstraZeneca

AstraZeneca expects US trial results in next 4-6 weeks
World

AstraZeneca expects US trial results in next 4-6 weeks

  • "I think we're getting very close to getting data. I would say in the next four to six weeks we should have the results for that study reading out,"
  • Some experts had expected the data sooner than that, given the high infection rates in the United States during the period of testing.
Published 05 Feb, 2021 08:46pm
Sinopharm vaccine not suitable for people above 60, pregnant women: SAPM Dr. Faisal Sultan
World

Sinopharm vaccine not suitable for people above 60, pregnant women: SAPM Dr. Faisal Sultan

  • According to the country's top health authorities, the Chinese manufactured Sinopharm vaccine is not suitable and recommended for people above the age of 60, under the age of 18, and specifically for pregnant women - among others.
  • According to Dr. Faisal Sultan, Special Assistant to the Prime Minister, people above 60 would be vaccinated with Oxford-AstraZeneca’s vaccine AZD1222, which is due for arrival in Pakistan in February.
Published 04 Feb, 2021 01:57pm